Elroy PW, Ronquest NA, Barnes A, Nadipelli VR, Akehurst R. Evaluating the effectiveness of treatments of opioid use disorder based on recovery outcomes: how to bridge the disconnect between clinical trial outcomes and recovery outcomes? Poster presented at the 2016 ISPOR 19th Annual European Congress; October 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A361.
Mladsi D, Ronquest N, Odom D, Miles L, Saag K. Cost-effectiveness of low-dose submicron diclofenac compared with generic diclofenac. Clin Ther. 2016 Nov;38(11):2418-29. doi: 10.1016/j.clinthera.2016.09.013
Cranmer H, Ronquest NA, Barnes A, Nadipelli VR, Akehurst R. To what extent does the published economic analyses of treatments for opioid use disorder capture its chronic, relapsing nature and its impact on society? Poster presented at the 2016 ISPOR 19th Annual European Congress; November 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A373.
Cranmer H, Ronquest NA, Barnes A, Nadipelli VR, Akehurst R. Health-related quality of life in opioid use disorder measured by utilities: a systematic literature review. Poster presented at the 2016 ISPOR 19th Annual European Congress; November 2016. Vienna, Austria. [abstract] Value Health. 2016 Nov; 19(7):A387.
Tkacz J, Brady B, Nadipelli V, Volpicelli J, Ronquest N, Un H, Ruetsch C. Opioid use disorder population: who is at risk of medication assisted treatment non-adherence? Poster presented at the 2016 AATOD Conference; October 31, 2016. Baltimore, MD.
Wollschlaeger BA, Montejano LB, Wilson TM, Ronquest N, Nadipelli VR. How do patients diagnosed with opioid use disorders compare to the overall US population of individuals with drug use disorder? Poster presented at the 29th Annual U.S. Psychiatric & Mental Health Congress; October 2016. San Antonio, TX.
Wollschlaeger B, Montejano LB, Wilson TM, Ronquest N, Juneau PL, Nadipelli VR. Real-world evidence: buprenorphine adherence predictive of reduced risk of opioid relapse. Poster presented at the 2016 Academy of Managed Care Pharmacy Nexus; October 2016. National Harbor, MD. [abstract] J Manag Care Spec Pharm. 2016 Oct; 22(10-a):S43.
Wollschlaeger B, Montejano L, Willson T, Ronquest N, Juneau P, Nadipelli V. Factors associated with buperhorphine medication assisted treatment adherence in patients diagnosed with opioid use disorder. Poster presented at the 29th Annual U.S. Psychiatric & Mental Health Congress; October 2016. San Antonio, TX.
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH, Han JJ. Factors associated with opioid overdose: a 10-year retrospective study of patients in a large integrated health care system. Subst Abuse Rehabil. 2016 Sep 16;7:131-41. doi: 10.2147/SAR.S108302
Boscarino JA, Kirchner HL, Pitcavage JM, Nadipelli VR, Ronquest NA, Fitzpatrick MH. A 10 year retrospective study of opioid overdoses among patients in a large integrated healthcare system. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA.
Montejano LB, Ronquest NA, Willson TM, Wollschlaeger BA, Cole AL, Nadipelli VR. How to measure 'opioid relapse' in real-world claims data. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A72.
Tkacz JMS, Brady B, Nadipelli VR, Volpicelli J, Ronquest NA. The association between buprenorphine medication assisted treatment adherence and healthcare service utilization and costs. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A187.
Ronquest N, Wollschlaeger B, Montejano L, Wilson T, Nadipelli V. Characteristics and treatment patterns of US medicaid patients with opioid use disorder. Poster presented at the 2016 International Conference on Opioids Conference; June 2016. Boston, MA. [abstract] J Opioid Manag. 2016 May; 12(3):227.
Brady B, Tkacz JMS, Nadipelli VR, Volpicelli J, Ronquest NA, Un H, Ruetsch C. Relapse in opioid use disorder: implications for healthcare utilization and costs. Poster presented at the 2016 ISPOR 21st Annual International Meeting; May 2016. Washington, DC. [abstract] Value Health. 2016 May; 19(3):A188.
Willson T, Montejano L, Wollschlaeger B, Ronquest N, Nadipelli V. Real-world dosing patterns among patients receiving buprenorphine for opioid dependence in the United States. Poster presented at the 2016 AMCP Managed Care & Specialty Pharmacy Annual Meeting; April 2016. San Francisco, CA. [abstract] J Manag Care Pharm. 2016 Apr; 22(4-a):S60.